Virtual Reality in Reducing Acute Orthopedic Pain
1 other identifier
interventional
100
1 country
1
Brief Summary
The primary aim of this research is to show that a virtual reality (VR) service line is feasible and can sustain itself with the ability to take care of patients. Additionally, the investigators aim to learn about the limitations of a service line and provide a pathway for future improvements in building a VR service line that is optimally aligned with the user's needs. Secondary aims are to evaluate the clinical aspects of the patient's outcomes including length of stay, morphine equivalents in pain medicine required during the hospital stay, and user experiences.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 17, 2024
CompletedFirst Posted
Study publicly available on registry
October 3, 2024
CompletedStudy Start
First participant enrolled
April 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
May 5, 2026
May 1, 2026
1.7 years
September 17, 2024
May 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
opioid use
Change in opioid equivalents during hospital stay from hospital admission to discharge
From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks
Secondary Outcomes (4)
reduction in anxiolytics
From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks
hospital length of stay
From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks
reduction in sleep aids prescribed
From date of enrollment which begins at hospital admission until the date of hospital discharge, assessed up to 5 weeks
User experiences
obtained once on the day of hospital discharge, up to 5 weeks from study enrollment
Study Arms (2)
Virtual reality
EXPERIMENTALIntervention with virtual reality
Standard of care
NO INTERVENTIONNo virtual reality intervention
Interventions
Eligibility Criteria
You may qualify if:
- Hospitalized with an orthopedic fracture
- Able to participate fully in all aspects of the study
- Able to understand and sign informed consent
- Individuals with unaided vision or those who can correct their vision using contact lenses
You may not qualify if:
- Non-English speaking
- Self-reported history of acute and/or chronic severe motion sickness
- The presence of a facial/head deformity that will prohibit the wearing of a VR head mounted display.
- Legally blind or deaf
- Have had a seizure within the past 1 year
- Have current (within the past 30 days) clinically significant acute or chronic progressive or unstable/uncontrolled neurologic disorder
- Have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic Hospital
Jacksonville, Florida, 32224, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Scott Helgeson, MD
Mayo Clinic
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant, Assistant Professor of Medicine
Study Record Dates
First Submitted
September 17, 2024
First Posted
October 3, 2024
Study Start
April 23, 2026
Primary Completion (Estimated)
January 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
May 5, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share